Regis Corp Form 4: SVP Michelle DeVore Receives 2,500-Share Award
Rhea-AI Filing Summary
Michelle St. DeVore, Senior Vice President, Marketing at Regis Corporation (RGS), reported an award-based acquisition of 2,500 shares of Regis common stock on 09/05/2025. The transaction price is reported as $0, indicating a grant rather than an open-market purchase. Following the reported transaction, the reporting person beneficially owns 5,000 shares. The award vests in three equal annual tranches: one-third on each of the first, second, and third anniversaries of the grant date, subject to continued employment and the grant terms. The Form 4 was signed by power-of-attorney on 09/09/2025.
Positive
- Reporting compliance: Timely Form 4 filing documents the insider award and meets Section 16 disclosure requirements.
- Alignment with long-term incentives: Award vests 1/3 annually over three years, tying compensation to continued employment and future performance.
Negative
- None.
Insights
TL;DR: Insiders received 2,500 restricted shares; ownership rose to 5,000 shares, a routine compensation grant with time-based vesting.
The reported transaction is a standard equity compensation award rather than a market purchase. A grant of 2,500 shares that vests 1/3 annually aligns management incentives with shareholder value over a three-year horizon. Because the price is reported as $0, this appears to be a restricted stock award or similar form of compensation. For investors, the event is not dilutive at a material level absent information about total outstanding shares or other concurrent grants. This is a routine disclosure required under Section 16.
TL;DR: The filing documents a time-based equity grant to an officer; governance implications are routine and limited.
The filing shows compliance with Section 16 reporting for an officer-level restricted share award. Vesting over three anniversaries is a common retention mechanism. There are no indications of accelerated vesting, related-party transactions, or changes in control provisions disclosed in this Form 4. The disclosure is standard practice and does not by itself indicate governance concerns or extraordinary compensation arrangements.
FAQ
What did Michelle St. DeVore report on Form 4 for RGS?
Was the 2,500-share transaction a purchase or a grant?
How does the award vest according to the Form 4?
What is Michelle St. DeVore's role at Regis Corporation noted in the filing?
When was the Form 4 signed and by whom?